A new boron agent drastically improves the effectiveness of boron neutron capture therapy for glioblastoma, demonstrate researchers at Tokyo Tech. The agent is selectively absorbed by brain tumor ...

Researchers from the Health Research and Technology Group at ANSTO and the University of Wollongong have developed a new device that could improve the quality control of accelerator-based boron ...

HSINCHU, Taiwan--(BUSINESS WIRE)--On February 14 th the melodious strains of the fourth movement of Mahler's Fifth Symphony were heard inside the building of Tsing Hua Open pool Reactor (THOR) at ...

Boron neutron capture therapy (BNCT) is a binary radiotherapeutic modality that exploits the nuclear capture reaction between the stable isotope boron-10 and low-energy neutrons. Following selective ...

IRVINE, Calif.--(BUSINESS WIRE)--TAE Life Sciences, in collaboration with Kyoto University and Principal Investigator Dr. Fuyuhiko Tamanoi, is pleased to announce groundbreaking preclinical results in ...

Distribution and failure patterns of primary central nervous system lymphoma related to the hippocampus: Implications for hippocampal sparing irradiation. This is an ASCO Meeting Abstract from the ...

Companies sign MOU to develop proton therapy and boron neutron capture therapy integration | Jun. 26, 2026 13:09 ...

Boron agents termed GluBs, developed by Science Tokyo researchers, have overcome a key limitation in cancer therapy by entering tumor cells through a pathway that standard drugs cannot use. The GluBs ...

In its first trial designed to evaluate boron neutron capture therapy (BNCT) in the treatment of advanced refractory malignant tumors, Neuboron Medtech Ltd. has performed 14 irradiations on a dozen ...

Neuboron Medtech Research Institute Ltd. has disclosed boron-containing lipoic acid derivatives and vesicle forms acting as boron neutron capture therapy (BNCT) agents reported to be useful for the ...